Carignan D - Search Results

1

Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.

Carignan D, Thérien A, Rioux G, Paquet G, Gagné ML, Bolduc M, Savard P, Leclerc D. Carignan D, et al. Vaccine. 2015 Dec 16;33(51):7245-7253. doi: 10.1016/j.vaccine.2015.10.123. Epub 2015 Nov 6. Vaccine. 2015. PMID: 26549362

2

Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.

Rioux G, Carignan D, Russell A, Bolduc M, Gagné MÈ, Savard P, Leclerc D. Rioux G, et al. Among authors: carignan d. J Nanobiotechnology. 2016 Jun 10;14(1):43. doi: 10.1186/s12951-016-0200-2. J Nanobiotechnology. 2016. PMID: 27282291 Free PMC article.

3

A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.

Thérien A, Bédard M, Carignan D, Rioux G, Gauthier-Landry L, Laliberté-Gagné MÈ, Bolduc M, Savard P, Leclerc D. Thérien A, et al. Among authors: carignan d. J Nanobiotechnology. 2017 Jul 18;15(1):54. doi: 10.1186/s12951-017-0289-y. J Nanobiotechnology. 2017. PMID: 28720097 Free PMC article.

4

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Bolduc M, Baz M, Laliberté-Gagné MÈ, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D. Bolduc M, et al. Among authors: carignan d. Nanomedicine. 2018 Nov;14(8):2563-2574. doi: 10.1016/j.nano.2018.08.010. Epub 2018 Sep 5. Nanomedicine. 2018. PMID: 30193813

5

Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist.

Carignan D, Herblot S, Laliberté-Gagné MÈ, Bolduc M, Duval M, Savard P, Leclerc D. Carignan D, et al. Nanomedicine. 2018 Oct;14(7):2317-2327. doi: 10.1016/j.nano.2017.10.015. Epub 2017 Nov 8. Nanomedicine. 2018. PMID: 29128662

6

Immunosuppressive effect of isopropanol: down-regulation of cytokine production results from the alteration of discrete transcriptional pathways in activated lymphocytes.

Désy O, Carignan D, Caruso M, de Campos-Lima PO. Désy O, et al. Among authors: carignan d. J Immunol. 2008 Aug 15;181(4):2348-55. doi: 10.4049/jimmunol.181.4.2348. J Immunol. 2008. PMID: 18684924

7

The dysregulation of the monocyte/macrophage effector function induced by isopropanol is mediated by the defective activation of distinct members of the AP-1 family of transcription factors.

Carignan D, Désy O, de Campos-Lima PO. Carignan D, et al. Toxicol Sci. 2012 Jan;125(1):144-56. doi: 10.1093/toxsci/kfr283. Epub 2011 Oct 20. Toxicol Sci. 2012. PMID: 22020770

8

Methanol induces a discrete transcriptional dysregulation that leads to cytokine overproduction in activated lymphocytes.

Désy O, Carignan D, Caruso M, de Campos-Lima PO. Désy O, et al. Among authors: carignan d. Toxicol Sci. 2010 Oct;117(2):303-13. doi: 10.1093/toxsci/kfq212. Epub 2010 Jul 8. Toxicol Sci. 2010. PMID: 20616203

9

Short-term immunological effects of non-ethanolic short-chain alcohols.

Désy O, Carignan D, de Campos-Lima PO. Désy O, et al. Among authors: carignan d. Toxicol Lett. 2012 Apr 5;210(1):44-52. doi: 10.1016/j.toxlet.2012.01.005. Epub 2012 Jan 13. Toxicol Lett. 2012. PMID: 22266471 Review.

10

The size of the unbranched aliphatic chain determines the immunomodulatory potency of short and long chain n-alkanols.

Carignan D, Désy O, Ghani K, Caruso M, de Campos-Lima PO. Carignan D, et al. J Biol Chem. 2013 Aug 23;288(34):24948-55. doi: 10.1074/jbc.M113.466334. Epub 2013 Jul 9. J Biol Chem. 2013. PMID: 23839943 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters